Clinical trial
LC-REVITALIZE - A Long Covid Repurposed Drug Study
NCT06928272 is registered in ClinicalTrials.gov with Douglas D. Fraser as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LC-REVITALIZE - A Long Covid Repurposed Drug Study
- Lead sponsor
- Douglas D. Fraser
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 10, 2025
- Completion date
- December 31, 2027
- Enrollment
- 348 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
long covid